SS

Sanchit Sood

Active Director Director DIN 09193093
DIN 09193093 First appointment Jun 2021 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2021
Shareholding value •••• Premium profile

About Sanchit Sood

Data last updated:

Sanchit Sood is a Director at Caveat Pharma Private Limited (since 2021). The company operates in Trading. Caveat Pharma Private Limited reported revenue of ₹23.2 Lakh (FY 2024).

DIN 09193093
Primary Designation Director
Industry Trading
First Appointment 03 Jun 2021
Oldest Company Age 19 yrs
Largest company Caveat Pharma Private Limited · ₹23.2 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Caveat Pharma Private Limited U24119PB2007PTC031229
Director03 Jun 20212007₹23.2 Lakh (FY 2024)Active

Board colleagues of Sanchit Sood

NameDINCompanyDesignation
Jaya Sood09192938Caveat Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Caveat Pharma Private Limited
Premium access

Shareholding and investment profile for Sanchit Sood

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sanchit Sood

Sanchit Sood currently holds 1 directorship: Caveat Pharma Private Limited (Director, since 03 Jun 2021, revenue ₹23.2 Lakh (FY 2024)).

Sanchit Sood was first appointed on 03 Jun 2021 as Director at Caveat Pharma Private Limited.

The current boards of Sanchit Sood's companies include Jaya Sood (Caveat Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available